Mirabegron 50 mg once daily, long-term treatment maximizes benefit in middle-aged and older people with overactive bladder syndrome: a systematic review and meta-analysis of nine phase II/III, randomized, double-blind, parallel-design, placebo-controlled, multicenter, and multinational trials
Xiangxiang Zhang, Yinhui Mao, Yang Liu, Jilei Sun, Juntao Sun, Chen-li Pan, Zhuo Wang, Zhitao Wei, Yong Yang
Frontiers in Surgery